#Commodity Project Id

One sector that has been growing at a fast pace in india over past few years is the CDMO sector i.e contract development and manufacturing its a very important part of the pharmaceutical supply chain in simple terms it is international companies outsourcing research and manufacturing to indian companies some of the oldest CDMO companies in india are divis lab and piramal pharma which have already seen huge rallies but here is where it gets interesting one very big positive triggers for CDMO companies is the US biosecure act that was recently passed in September The US Biosecure Act aims to move its supply chains away from China, presenting a huge opportunity for India’s pharma industry the biosecure act proposes to ban chinese biotech companies operating in the US veteran investor madhu kela recently said the CDMO sector in india can grow five fold in the next decade because of the geopolitical tension between US and China, a lot of contract manufacturing that was meant for china could now further move to india india has become a very appealing CDMO destination due to low manufacturing prices, foreign direct investments and government incentives like the PLI scheme companies that are right up there in CDMO manufacturing are Divis labs , piramal pharma, laurus labs, syngene , neuland labs and suven pharma 58% of piramal pharma sales comes from CDMO services Piramal pharma aims to double its turnover to $2 bn by 2030, driven by the CDMO business Jonathan Hunt of Syngene has observed a ‘material shift’ in Big Pharma’s sourcing strategies to mitigate risks. Syngene has indicated that it is participating in pilot projects related to the ‘China Switch’ opportunity and has seen a 50% year-over-year increase in RFPS in terms of value in the first quarter—its best performance in four years. The synergy of the US Biosecure Act, India’s robust manufacturing capabilities, and rising global demand creates a lucrative opportunity for domestic firms. What do you think ? Disclaimer: these are not recommendations , please consult your SEBI registered investment advisor before any investment

CENTRAL MINE PLANNING IPO 📈🚀LISTING STRATEGY | FRESH BUY LEVELS 😍🔥 #cmpdi #cmpdiipo #centralmineplanningipo #listingstrategy #ipomarket ✅ CMPDI IPO 😎💪 LISTING WILL BE ??

SIM Cards to a Gold Bar (Props) ✨ #metalmelting #propmaking #satisfying

CMPDI IPO!🪨⛏️ 💥 Listing gain ke sapne… ya phir reality check? 😏 CMPDI ka ₹1840 Cr ka IPO aa chuka hai 🚀 Par sawaal ek hi hai — apply kare ya skip? 🤔 📊 Quick breakdown: 👉 Cut-off: ₹172 👉 Lot size: ₹13,760 (80 shares) 🔥 Sabse bada फायदा: 👉 Agar aapke paas Coal India ka 1 share bhi hai 👉 Toh 2 applications laga sakte ho 💰 (1 Retail + 1 Shareholder quota 😎) 📈 Company ka game: 👉 Mining consultancy 🏭 👉 Coal & minerals kaha milenge + kaise niklega — sab plan karta hai 📊 Growth numbers strong hai: 👉 Revenue: +23% 📈 👉 EBITDA: +52% 🔥 👉 Profit: +50% 💸 👉 Cash flow: Consistently positive ✅ ⚖️ Valuation: 👉 PE ~18 → na mehenga, na sasta 🤝 🚨 Red flag: 👉 GMP sirf ~1% 😶 👉 Market global war news se already weak 📉 👉 Business heavily coal sector pe dependent ⛏️ 🧠 Mera take: 👉 Fundamentals theek hai 👉 But listing gain ke chances low 👉 Isliye main apply nahi kar raha ❌ 📲 Aap kya karoge — apply ya skip? Aur haan… ye reel unko zarur bhejo jo har IPO me bina soche ghus jaate hai 😅 #IPOIndia #StockMarketIndia #InvestSmart #ListingGains #ShareMarket

Ecosistema Caracas Commodity Exchange🧠 #venezuelalotienetodo 🇻🇪 Síguenos para más✅

PART 2 | Commodity NYC Flagship 🗽 First impressions on the new Commodity Ice(d) range, live from the NYC flagship store. We checked out all 3 versions of Ice(d) across Bold, Expressive and Personal to see how the same scent changes through Commodity’s Scent Space concept. If you’ve been curious about the new launch, this is Episode 2 of my Commodity NYC mini series. @commodity @commodity_nyc @albertosantos19 #FragranceTok #fragrance #perfumetiktok #perfumes #CommodityFragrances

Clean, icy, and effortlessly magnetic. The perfect gift, wrapped and waiting. ❄️✨ Ice(d) is available now @commodity @sephora @sephoracanada #CommodityPartner #CommodityIced

💊Contract Development Manufacturing Organisation - CDMO 🚨Few CMDO stocks to keep in your watchlist along with their key strengths 👉Divi’s Laboratories - Global Leader, US / EU Clients 👉Laurus Labs - R&D, Biomanufacturing 👉Syngene International - Innovation, Global Contracts 👉Blue Jet Healthcare - Regulatory Strength, Advanced Molecules 👉Glad Pharma - Regulatory Strength, US / EU Exports 👉Piramal Pharma - Strong Global Presence, Promoter Backing 👉Neuland Labs - Regulatory Strength, Specialty Focus 👉Jubilant Pharmova - Strong Product Pipeline, Diversified Services 👉Aarti Pharmalabs - Integrated Chemical Manufacturing 👉Zydus Lifesciences - Large Scale API / Biosimilars Production Despite excellent results Blue Jet Healthcare has crashed 20% in two days Most people think it’s because of flat QoQ results I attended the Concall - the management clearly said that figures should not be compared on a QoQ basis, it should always be compared YoY One important fact is that promoters still hold 86% shareholding Personally I think the promoters have sold stake when the stock crossed ₹1,000 levels couple of days ago. Some large block deals may be happening post results 👌Results were very encouraging 🤷🏻Promoter selling (if it turns out to be true) is NOT a matter of concern I remain very constructive on Blue Jet for the medium and long term 🚨Disclaimer: This is just my opinion, not a recommendation. Please do your own research #stockmarket #stockmarketindia #ShareMarket #sharemarketindia #stocks #investing #investment #trading #reels #explore #nifty #sensex #pharma

This was my first experience organizing a project like this. It was a fairly straightforward project to ‘general contract’ and I’d do it again in the future. I can see why people choose to just have a local bin dealer general contract a bin project though.

Riding the Pharma Wave! 🌍 India’s CDMO market is surging towards $45B by 2029 🚀💊 From cutting-edge therapies to game-changing expansions, these pharma giants are shaping the future! Which one are you rooting for? 🏆✨ 💀 Disclaimer: Any stock shown in the content/post/story shouldn’t be considered any tip/advice to invest/trade. These are only for educational & informational purposes. #PharmaStocks #CDMOIndia #IndiaGrowthStory #Investing #GlobalCDMOHub #DivisLaboratories #SyngeneInternational #GlandPharma #DrReddys #StockMarket #MarketLeaders #Biopharmaceuticals #AdvancedTherapies #CellAndGeneTherapy #BiotechInvestments #AntibodyDrugConjugates #NucleicAcidTherapeutics #IndiaEconomicGrowth #SterileInjectables #ContractManufacturing #RFP #GenomeValley #HealthcareInvesting #IndiaPharma #StockMarketTips #PLI

Comment 250 for 250 project ideas in all domains. Make use of this in upcoming hackathons #project #sih #engineeringlife #follow #viral

COMEX vaults are being drained of physical silver at one of the fastest paces in recent years. In January 2026 alone, 49.4 million ounces were delivered — compared to 11.8 million ounces in January 2025 and just 6.8 million ounces two years ago. That’s over 7x higher than 2024 levels. At the same time, registered silver available for delivery recently stood near 103 million ounces — a multi-year low. Meanwhile, open contracts represent roughly 429 million ounces that could stand for delivery in March. Not all contracts demand physical. But even 25% participation would materially tighten inventories. This isn’t hype. It’s math. When physical demand accelerates while paper markets dominate price discovery, volatility increases. Exchanges respond with tools like margin hikes and delivery rule adjustments — and short-term traders feel it first. Understand the difference between: • 429m ounces open • 103m ounces registered • Paper positioning • Physical supply Short-term moves are driven by leverage. Long-term moves are driven by supply and demand. Know which side you’re exposed to. #Silver #Gold #Commodities #Macro #Investing